Osimertinib in patients with T790M mutation positive advanced non-small cell lung cancer (NSCLC): Korean subgroup analysis from pooled phase II data

被引：0
|
作者：
Ahn, M-J [1 ]
Lee, J-S. [2 ]
Han, J-Y. [3 ]
Kim, D-W. [4 ]
Cho, B. C. [5 ]
Kang, J. H. [6 ]
Kim, S-W. [7 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Sect Hematol Oncol, Seoul, South Korea
[2] Seoul Natl Univ, Bundang Hosp, Div Hematol Oncol, Gyeonggi Do, South Korea
[3] Natl Canc Ctr, Res Inst & Hosp, Lung Canc Branch, Gyeonggi Do, South Korea
[4] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
[5] Yonsei Canc Ctr, Div Med Oncol, Seoul, South Korea
[6] Seoul St Marys Hosp, Dept Med Oncol, Seoul, South Korea
[7] Asan Med Ctr, Dept Oncol, Seoul, South Korea
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
468P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Osimertinib in Patients with T790M-Positive Advanced Non-small Cell Lung Cancer: Korean Subgroup Analysis from Phase II Studies
    Ahn, Myung-Ju
    Han, Ji-Youn
    Kim, Dong-Wan
    Cho, Byoung Chul
    Kang, Jin-Hyoung
    Kim, Sang-We
    Yang, James Chih-Hsin
    Mitsudomi, Tetsuya
    Lee, Jong Seok
    [J]. CANCER RESEARCH AND TREATMENT, 2020, 52 (01): : 284 - 291
  • [2] Osimertinib for EGFR T790M mutation-positive non-small cell lung cancer
    Soejima, Kenzo
    Yasuda, Hiroyuki
    Hirano, Toshiyuki
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (01) : 31 - 38
  • [3] Osimertinib for Japanese patients with T790M-positive advanced non-small-cell lung cancer: A pooled subgroup analysis
    Hirashima, Tomonori
    Satouchi, Miyako
    Hida, Toyoaki
    Nishio, Makoto
    Kato, Terufumi
    Sakai, Hiroshi
    Imamura, Fumio
    Kiura, Katsuyuki
    Okamoto, Isamu
    Kasahara, Kazuo
    Uchida, Hirohiko
    Vowler, Sarah L.
    Mitsudomi, Tetsuya
    [J]. CANCER SCIENCE, 2019, 110 (09) : 2884 - 2893
  • [4] Osimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trial
    Kazuhisa Nakashima
    Yuichi Ozawa
    Haruko Daga
    Hisao Imai
    Motohiro Tamiya
    Takaaki Tokito
    Takahisa Kawamura
    Hiroaki Akamatsu
    Yuko Tsuboguchi
    Toshiaki Takahashi
    Nobuyuki Yamamoto
    Keita Mori
    Haruyasu Murakami
    [J]. Investigational New Drugs, 2020, 38 : 1854 - 1861
  • [5] Osimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trial
    Nakashima, Kazuhisa
    Ozawa, Yuichi
    Daga, Haruko
    Imai, Hisao
    Tamiya, Motohiro
    Tokito, Takaaki
    Kawamura, Takahisa
    Akamatsu, Hiroaki
    Tsuboguchi, Yuko
    Takahashi, Toshiaki
    Yamamoto, Nobuyuki
    Mori, Keita
    Murakami, Haruyasu
    [J]. INVESTIGATIONAL NEW DRUGS, 2020, 38 (06) : 1854 - 1861
  • [6] AZD9291 in pre-treated patients with T790M positive advanced non-small cell lung cancer (NSCLC): Pooled analysis from two Phase II studies
    Goss, G. D.
    Yang, J. C. H.
    Ahn, M. J.
    Tsai, C. M.
    Bazhenova, L.
    Sequist, L. V.
    Ramalingam, S. S.
    Shepherd, F. A.
    Ghiorghiu, S.
    Cantarini, M.
    Mann, H.
    Mitsudomi, T.
    Jaenne, P. A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S640 - S640
  • [7] Osimertinib for the Treatment of Metastatic EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer
    Khozin, Sean
    Weinstock, Chana
    Blumenthal, Gideon M.
    Cheng, Joyce
    He, Kun
    Zhuang, Luning
    Zhao, Hong
    Charlab, Rosane
    Fan, Ingrid
    Keegan, Patricia
    Pazdur, Richard
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (09) : 2131 - 2135
  • [8] Targeting the Gatekeeper: Osimertinib in EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer
    Skoulidis, Ferdinandos
    Papadimitrakopoulou, Vassiliki A.
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (03) : 618 - 622
  • [9] Osimertinib in Patients With T790M Mutation-Positive, Advanced Non-Small Cell Lung Cancer: Long-Term Follow-Up From a Pooled Analysis of 2 Phase 2 Studies
    Ahn, Myung-Ju
    Tsai, Chun-Ming
    Shepherd, Frances A.
    Bazhenova, Lyudmila
    Sequist, Lecia, V
    Hida, Toyoaki
    Yang, James C. H.
    Ramalingam, Suresh S.
    Mitsudomi, Tetsuya
    Janne, Pasi A.
    Mann, Helen
    Cantarini, Mireille
    Goss, Glenwood
    [J]. CANCER, 2019, 125 (06) : 892 - 901
  • [10] Real-Life Data of Osimertinib in Pretreated Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR T790M Mutation
    Alfaro Autor, C.
    Romero, A.
    Calvo De Juan, V.
    Franco, F.
    Sanchez Romero, E.
    Ortiz Cortes, N.
    Sanz Moreno, S.
    Rodriguez Festa, A.
    Serna Blasco, R.
    Barquin Del Romo, M.
    Provencio, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1036 - S1036
12345